We hereby submit Monitoring Agency Report for the quarter ended March 31, 2026 - IPO.
YATHARTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings Limited, the monitoring agency for Yatharth Hospital's IPO (Rs. 610 crore, listed July 2023), has submitted its Q4 FY26 report. Out of the total IPO proceeds of Rs. 569.71 crore, Rs. 521.26 crore (91.5%) has been utilised. Rs. 48.45 crore remains unutilised, parked in Axis Bank fixed deposits earning 5.50%-6.25% interest. Three categories face ongoing delays: repayment of subsidiary borrowings (Rs. 142.72 crore of Rs. 145 crore utilised, Rs. 2.28 crore pending), subsidiary capital expenditure (Rs. 64.23 crore of Rs. 106.97 crore utilised, Rs. 42.74 crore pending), and general corporate purposes (Rs. 123.67 crore of Rs. 127.10 crore utilised, Rs. 3.43 crore pending). The monitoring agency flags ongoing delays in the implementation timeline and warns this may lead to cost overruns affecting the viability of the objects. No formal approval for the delay has been received from regulators.
The ongoing delays in deployment of IPO funds, particularly for subsidiary borrowings and capex, signal execution challenges. Investors should monitor whether cost overruns emerge and whether shareholder approval for material deviations is sought as the timeline extends beyond the originally planned FY24-FY25 completion dates.